Safety and Efficacy of Metformin for Therapy-induced Hyperglycemia in Children With Acute Lymphoblastic Leukemia
Authors:
- Bruce BostromBBBruce Bostrom
- Priya Ba UppalPUPriya Ba Uppal
- Julie ChuJCJulie Chu
- Yoav MessingerYMYoav Messinger
- 1 October 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 35 (7) , 504-508
Abstract
Background: Hyperglycemia during corticosteroid and asparaginase therapy for acute lymphoblastic leukemia is a significant side effect that is usually treated with insulin. Metformin is an oral antidiabetic biguanide that may cause metabolic acidosis and liver enzyme abnormalities of possible concern in patients receiving chemotherapy. Procedure: We reviewed patients with acute lymphoblastic leukemia treated with corticosteroids and asparaginase who received metformin for control of hyperglycemia. Results: Seventeen patients received metformin, including 4 who received insulin before starting metformin therapy. Twelve were treated during initial induction therapy and 5 during relapse reinduction. Corticosteroids included dexamethasone in 11, prednisone in 5, and megesterol in 1. Fifteen received pegasparaginase. Patients were treated with metformin for a median of 6 days (range, 2 to 46 d). Metformin was started at a median glucose level of 286 mg/dL (range, 112 to 499 mg/mL). The glucose level was controlled with metformin alone in 12 patients without the need for insulin. Four patients received insulin before or concomitantly with metformin. In 1 patient, metformin failed to control the glucose level, and insulin was administered. No significant toxicity from metformin was seen. Two patients had an elevated anion gap and creatinine level because of extreme hyperglycemia. One patient had mild elevation in total bilirubin and 5 patients had mild elevation in serum alanine aminotransferase levels. There were no episodes of hypoglycemia. Conclusions: Metformin is safe and effective for therapy-induced hyperglycemia. Initially, insulin may be required for significant hyperglycemia or metabolic abnormalities. We are unaware of any prior studies using metformin in this population.Keywords
This publication has 7 references indexed in Scilit:
- Lactic Acidosis Induced by MetforminDrug Safety, 2010
- Clarifying metformin's role and risks in liver dysfunctionJournal of the American Pharmacists Association, 2010
- Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignanciesBritish Journal of Haematology, 2009
- Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemiaPediatric Blood & Cancer, 2009
- Toxic Effects from Metformin ExposureAnnals of Pharmacotherapy, 2004
- Endocrine complications in pediatric patients with acute lymphoblastic leukemiaBlood Reviews, 2002
- Hyperglycemia associated with the therapeutic use of l-asparaginase: Possible role of insulin receptorsThe Journal of Pediatrics, 1978